Weight Loss Breakthroughs

Liraglutide, initially approved for diabetes, demonstrated variable weight loss effects, with nausea as a notable side effect that many users adapted to over time. The introduction of semaglutide marked a significant advancement, boasting a longer half-life and leading to impressive weight loss results of up to 16%. These developments highlight the evolving landscape of weight loss drugs and the intriguing mechanisms behind their effectiveness.